| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $172.4M | +627.8% |
| R&D Expense | $258.8M | +7.1% |
| SG&A Expense | $179.7M | +48.6% |
| Operating Income | -$273.1M | +19.6% |
| Income Tax | $433K | — |
| Net Income | -$285.4M | +10.5% |
| EPS (Basic) | -$3.29 | +11.6% |
| EPS (Diluted) | -$3.29 | +11.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $134.9M | -12.4% |
| Short-term Investments | $259.1M | -38.1% |
| Accounts Receivable | $38.0M | +399.8% |
| Inventory | $32.8M | +8849.2% |
| Current Assets | $528.1M | -12.4% |
| Total Assets | $529.7M | -26.9% |
| Current Liabilities | $120.1M | +16.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$323.0M | -17.5% |
| Capital Expenditures | $187K | — |
| Investing Cash Flow | $290.0M | +232.0% |
| Financing Cash Flow | $13.7M | -96.1% |
| Free Cash Flow | -$323.2M | -17.6% |
| Total Liabilities |
| $465.1M |
| +6.5% |
| Stockholders' Equity | $64.6M | -77.6% |